Serving leading biopharmaceutical companies globally:

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

PEGINTRON Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: PEGINTRON

Patents:	30
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for PEGINTRON

Recent Clinical Trials for PEGINTRON

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Third Affiliated Hospital, Sun Yat-Sen University	N/A
National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
University of Pennsylvania	Phase 1

See all PEGINTRON clinical trials

Pharmacology for PEGINTRON

Ingredient-type	Interferon Alfa-2b Interferon-alpha

Company Disclosures: US Patents for PEGINTRON

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX	Orphan	company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX	Orphan	company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX	Orphan	company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX	Orphan	company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2018-03-26	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for PEGINTRON

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE)	2031-04-05	RX	Orphan	search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Abbott Laboratories (Abbott Park, IL)	2023-03-24	RX	Orphan	search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX	Orphan	search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Roche Palo Alto LLC (Palo Alto, CA)	2039-02-26	RX	Orphan	search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for PEGINTRON

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	6063382	Start Trial
Hong Kong	1117761	Start Trial
Singapore	10201606646R	Start Trial
China	101189230	Start Trial
German Democratic Republic	210304	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Baxter

Harvard Business School

Dow

Express Scripts

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.